EDDING GENOR6998.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, EDDING GENOR (6998.HK) trades at a P/E of 13.60x, P/B of 0.72x, P/S of 1.31x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 84th percentile over the trailing 10Y window (vs. 84th percentile over 3Y); P/B sits at the 39th percentile over the trailing 10Y window (vs. 33rd percentile over 3Y); P/S sits at the 22nd percentile over the trailing 10Y window (vs. 37th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 38th percentile within its industry and the 60th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.12%, ranking at the 100th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 44.4 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Shareholder returns here lean heavily on buybacks rather than cash dividends. EDDING GENOR operates in the Biomedical II sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 6998 · SEHK: 6998 · 6998
Want the full picture on whether EDDING GENOR (6998.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 13.60 | ||||||
| P/B (MRQ) | 0.72 | ||||||
| P/S (TTM) | 1.31 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 3.12% |